{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:06:24Z","timestamp":1792760784587,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00259-020-04722-0","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T12:05:01Z","timestamp":1584965101000},"page":"2656-2665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism"],"prefix":"10.1007","volume":"47","author":[{"given":"Jie","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Kreissl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anli","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1216-083X","authenticated-orcid":false,"given":"Li","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"issue":"5","key":"4722_CR1","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(5):1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4722_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6(1):41\u201350.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"14","key":"4722_CR3","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69(14):1811\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"4722_CR4","first-page":"192874","volume":"2015","author":"LL Li","year":"2015","unstructured":"Li LL, Gu WJ, Dou JT, Yang GQ, Lv ZH, et al. Incidental adrenal enlargement: an overview from a retrospective study in a Chinese population. Int J Endocrinol. 2015;2015:192874.","journal-title":"Int J Endocrinol"},{"issue":"6","key":"4722_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/cen.13442","volume":"87","author":"AT Nanba","year":"2017","unstructured":"Nanba AT, Nanba K, Byrd JB, Shields JJ, Giordano TJ, Miller BS, et al. Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism. Clin Endocrinol. 2017;87(6):665\u201372.","journal-title":"Clin Endocrinol"},{"issue":"3","key":"4722_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/MED.0000000000000407","volume":"25","author":"GP Rossi","year":"2018","unstructured":"Rossi GP. Update in adrenal venous sampling for primary aldosteronism. Curr Opin Endocrinol Diabetes Obes. 2018;25(3):160\u201371.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"4722_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.14740\/jocmr3243w","volume":"10","author":"K Okamura","year":"2018","unstructured":"Okamura K, Okuda T, Shirai K, Abe I, Kobayashi K, Ishii T, et al. Persistent primary aldosteronism despite iatrogenic adrenal hemorrhage after adrenal vein sampling. J Clin Med Res. 2018;10(1):66\u201371.","journal-title":"J Clin Med Res"},{"key":"4722_CR8","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1186\/1756-0500-5-602","volume":"5","author":"BT Layden","year":"2012","unstructured":"Layden BT, Hahr AJ, Elaraj DM. Primary hyperaldosteronism: challenges in subtype classification. BMC Res Notes. 2012;5:602.","journal-title":"BMC Res Notes"},{"issue":"3","key":"4722_CR9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MED.0000000000000148","volume":"22","author":"AS Powlson","year":"2015","unstructured":"Powlson AS, Gurnell M, Brown MJ. Nuclear imaging in the diagnosis of primary aldosteronism. Curr Opin Endocrinol Diabetes Obes. 2015;22(3):150\u20136.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"4722_CR10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","volume":"71","author":"B Heinze","year":"2018","unstructured":"Heinze B, Fuss CT, Mulatero P, Beuschlein F, Reincke M, Mustafa M, et al. Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of aldosterone-producing adenoma. Hypertension. 2018;71(2):317\u201325.","journal-title":"Hypertension."},{"issue":"Suppl 2","key":"4722_CR11","doi-asserted-by":"crossref","first-page":"77S","DOI":"10.2967\/jnumed.116.186874","volume":"58","author":"AME Walenkamp","year":"2017","unstructured":"Walenkamp AME, Lapa C, Herrmann K, Wester HJ. CXCR4 ligands: the next big hit? J Nucl Med. 2017;58(Suppl 2):77S\u201382S.","journal-title":"J Nucl Med"},{"issue":"9","key":"4722_CR12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5(9):689\u201399.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4722_CR13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mce.2017.08.019","volume":"461","author":"K Itcho","year":"2018","unstructured":"Itcho K, Oki K, Kobuke K, Yoshii Y, Ohno H, Yoneda M, et al. Aberrant G protein-receptor expression is associated with DNA methylation in aldosterone-producing adenoma. Mol Cell Endocrinol. 2018;461:100\u20134.","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"4722_CR14","first-page":"e13353","volume":"73","author":"PM O\u2019Shea","year":"2019","unstructured":"O\u2019Shea PM, Griffin TP, Denieffe S, Fitzgibbon MC. The aldosterone to renin ratio (ARR) in the diagnosis of primary aldosteronism (PA): promises and challenges. Int J Clin Pract. 2019;73(7):e13353.","journal-title":"Int J Clin Pract"},{"issue":"7","key":"4722_CR15","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","volume":"101","author":"SC K\u00e4yser","year":"2016","unstructured":"K\u00e4yser SC, Dekkers T, Groenewoud HJ, van der Wilt GJ, Carel Bakx J, van der Wel MC, et al. Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis. J Clin Endocrinol Metab. 2016;101(7):2826\u201335.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"4722_CR16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","volume":"136","author":"WF Young","year":"2004","unstructured":"Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004;136(6):1227\u201335.","journal-title":"Surgery."},{"issue":"10","key":"4722_CR17","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2967\/jnumed.109.064873","volume":"50","author":"RF Yen","year":"2009","unstructured":"Yen RF, Wu VC, Liu KL, Cheng MF, Wu YW, Chueh SC, et al. 131I-6beta-iodomethyl-19-norcholesterol SPECT\/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results. J Nucl Med. 2009;50(10):1631\u20137.","journal-title":"J Nucl Med"},{"issue":"4","key":"4722_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1530\/EJE-10-1085","volume":"164","author":"T Wang","year":"2011","unstructured":"Wang T, Satoh F, Morimoto R, Nakamura Y, Sasano H, Auchus RJ, et al. Gene expression profiles in aldosterone-producing adenomas and adjacent adrenal glands. Eur J Endocrinol. 2011;164(4):613\u20139.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"4722_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1210\/jc.2011-1537","volume":"97","author":"TJ Burton","year":"2012","unstructured":"Burton TJ, Mackenzie IS, Balan K, Koo B, Bird N, Soloviev DV, et al. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn\u2019s adenomas. J Clin Endocrinol Metab. 2012;97(1):100\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"4722_CR20","doi-asserted-by":"publisher","unstructured":"Mendichovszky IA, Powlson AS, Manavaki R, Aigbirhio FI, Cheow H, Buscombe JR, et al. Targeted molecular imaging in adrenal disease-an emerging role for metomidate PET-CT. Diagnostics (Basel). 2016;6(4). https:\/\/doi.org\/10.3390\/diagnostics6040042.","DOI":"10.3390\/diagnostics6040042"},{"issue":"7","key":"4722_CR21","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1210\/jc.2012-3261","volume":"98","author":"MC Kreissl","year":"2013","unstructured":"Kreissl MC, Schirbel A, Fassnacht M, Haenscheid H, Verburg FA, Bock S, et al. [(1)(2)(3)I]Iodometomidate imaging in adrenocortical carcinoma. J Clin Endocrinol Metab. 2013;98(7):2755\u201364.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4722_CR22","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2012-3045","volume":"98","author":"S Hahner","year":"2013","unstructured":"Hahner S, Kreissl MC, Fassnacht M, Haenscheid H, Bock S, Verburg FA, et al. Functional characterization of adrenal lesions using [123I]IMTO-SPECT\/CT. J Clin Endocrinol Metab. 2013;98(4):1508\u201318.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4722_CR23","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1210\/jc.2012-3726","volume":"98","author":"K Nanba","year":"2013","unstructured":"Nanba K, Tsuiki M, Sawai K, Mukai K, Nishimoto K, Usui T, et al. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry. J Clin Endocrinol Metab. 2013;98(4):1567\u201374.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-04722-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-020-04722-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-04722-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T20:19:19Z","timestamp":1616444359000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-020-04722-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4722"],"URL":"https:\/\/doi.org\/10.1007\/s00259-020-04722-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]},"assertion":[{"value":"5 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"SCINTOMICS owns the IP on Pentixafor. All other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The clinical institutional review board approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}